Dr. Bardliving received his BS in Chemical Engineering from the University of Maryland, Baltimore County and completed his PhD in Biomedical Engineering from Cornell University. At Cornell his graduate work focused on pilot scale process development and production of CT antigens. As a post-doctoral associate, his work centered on research into scale-up and process characterization for several expression systems, including Pichia Pastoris and Aspergillus niger. In September 2015, he joined the Amgen Bioprocessing Center at KGI. His research focus is in process characterization and optimization of P. pastoris expression system for production of therapeutic agents. In addition his laboratory works on design and in silico modeling of novel fermentation systems for continuous culture. Dr. Bardliving, who joined KGI in September 2015, serves as director for the Bioprocessing PhD programs.
MEB 304: Molecular Biology and Biotechnology
MEB 303: Molecular Basis of Disease
ALS 410: Microbial Fermentation Lab